Yu Wang

发表

Design, synthesis and biological evaluation of novel thieno[3,2-d]pyrimidine derivatives possessing diaryl semicarbazone scaffolds as potent antitumor agents.

Jian Wang, P. Gong, Zijian Liu, 2014, European journal of medicinal chemistry.

Design and synthesis of novel 2-(4-(2-(dimethylamino)ethyl)-4H-1,2,4-triazol-3-yl)pyridines as potential antitumor agents.

X. Zhai, H. Xie, Yucheng Gu, 2014, European journal of medicinal chemistry.

Based on 2-(difluoromethyl)-1-[4,6-di(4-morpholinyl)-1,3,5-triazin-2-yl]-1H-benzimidazole (ZSTK474), design, synthesis and biological evaluation of novel PI3Kα selective inhibitors.

Yu Wang, Yanfang Zhao, Yajing Liu, 2022, Bioorganic chemistry.

Design and Synthesis of Novel 4‐Phenoxyquinolines Bearing 3‐Hydrosulfonylacrylamido or 1H‐Imidazole‐4‐carboxamido Scaffolds as c‐Met Kinase Inhibitors

X. Zhai, P. Gong, Yu Wang, 2017, Archiv der Pharmazie.

Design, synthesis and biological evaluation of novel 4-arylaminopyrimidine derivatives possessing a hydrazone moiety as dual inhibitors of L1196M ALK and ROS1.

X. Zhai, Daiying Zuo, P. Gong, 2016, European journal of medicinal chemistry.

Design, Synthesis, and Biological Evaluation of 4‐Phenoxyquinoline Derivatives Containing Benzo[d]thiazole‐2‐yl Urea as c‐Met Kinase Inhibitors

P. Gong, Zijian Liu, Yu Wang, 2016, Archiv der Pharmazie.

Discovery of novel 2,4-diarylaminopyrimidine analogues as ALK and ROS1 dual inhibitors to overcome crizotinib-resistant mutants including G1202R.

X. Zhai, Yucheng Gu, Daiying Zuo, 2018, European journal of medicinal chemistry.

5-chloro-N4-(2-(isopropylsulfonyl)phenyl)-N2-(2-methoxy-4-(4-((4-methylpiperazin-1-yl)methyl)-1H-1,2,3-triazol-1-yl)phenyl)pyrimidine-2,4-diamine (WY-135), a novel ALK inhibitor, induces cell cycle arrest and apoptosis through inhibiting ALK and its downstream pathways in Karpas299 and H2228 cells.

X. Zhai, Daiying Zuo, Zengqiang Li, 2018, Chemico-biological interactions.

Design, synthesis and biological evaluation of novel thieno[3,2-d]pyrimidine derivatives containing diaryl urea moiety as potent antitumor agents.

P. Gong, Dazhuang Zuo, Zijian Liu, 2014, European journal of medicinal chemistry.

Design, Synthesis and Structure-Activity Relationships of Novel Diaryl Urea Derivatives as Potential EGFR Inhibitors

Yu Wang, Xin Zhai, X. Zhai, 2016, Molecules.

Design and Synthesis of Novel 4‐Phenoxyquinolines Bearing 3‐Hydrosulfonylacrylamido or 1H‐Imidazole‐4‐carboxamido Scaffolds as c‐Met Kinase Inhibitors

X. Zhai, P. Gong, Yu Wang, 2017, Archiv der Pharmazie.